drugset / Trial / NCT01052662

Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults

NCT01052662

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine the effect of memantine and buprenorphine on opioid abusing behavior, to determine the effect of memantine and buprenorphine on early relapse and to evaluate the tolerability of memantine co-administrated with buprenorphine. The study seeks to determine if combined treatment of memantine and buprenorphine may provide shorter-term treatment for opioid dependence.

Timeline

Start
2009-10
Primary completion
2013-06
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 15 mg Oral
Subject Memantine Unknown 30 mg Oral

Indications